PATENT CLAIM ANALYSIS

Application Number: 15999239
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-04
Patent Classification: ["424", "085400"]

Abstract:
Methods of treating a hepatitis delta virus (HDV) infection in a human patient are provided. In some embodiments, the method comprising administering to the patient a therapeutically effective amount of interferon lambda for at least four weeks.

Claim (Index 11):
The method of any of  claims 1  to  10 , wherein the course of treatment results in an HDV viral load that is below 100 copies/mL serum or below 100 IU/mL serum.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 96.0
- Lexical Diversity: 1.16667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15335327', '13875253', '13119760', '15408087', '14449174']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426604436104539
- 35 USC 102 Novelty (BERT): 0.537294410099426
- Combined Prediction Score: 0.7221238402593512
- Mean Citation Score: 274.69786200000004
- Max Citation Score: 376.35223
- Similarity Product: 235.89468424325585

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test